Cadence Taps Latham For $100M Offering

Law360, New York (September 8, 2009, 4:34 PM EDT) -- Cadence Pharmaceuticals Inc. has registered for an aggregate initial offering of up to $100 million in securities with the U.S. Securities and Exchange Commission.

The offering allows for a combination of debt securities, preferred and common stock, debt warrants and equity warrants. It extends the company's window for selling securities and gives more flexibility regarding types of securities sales than its equity-only shelf offering from 2007.

“We thought it was prudent to make sure that we had all the tools available,” said William R. LaRue, senior...
To view the full article, register now.